Positive context积极背景
Stocks股票 / Health Care / TGTX
TG Therapeutics, Inc. · Health Care
TGTX US listed · USD美股 · 美元
Mid cap中盘 · $9B
Health Care
S&P 600标普600小盘Russell 2000罗素2000
Rate-sensitive利率敏感
$57.43
-$0.09 · -0.16%
52w low52周低 $26.39high高 $60.23
Extended — wait for a pullback过度拉伸 — 等待回撤
The low is already in and price has run. Wait for a pullback; hold if you're long.低点已经形成、价格已经拉升。等待回调再入场；若已持有可继续持有。
As of 2026-09-28截至 2026-09-28
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-28
Momentum (RSI 14)动量（RSI 14）
58
Neutral zone中性区域
vs 50-day average相对50日均线
+7.1% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+41.1% above上方
Long trend up长期向上
Volatility波动率
17th percentile第17百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0235
Estimates being cut预期下调
Mixed — beat 1 of last 4 quarters表现不稳 — 近 4 季中 1 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 184.7%
Valuation估值
Expensive vs sector相对行业偏贵| Multiple指标 | TGTX | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 19.94x | 29.58 | |
| P/B市净率 | 13.76x | 3.30 | |
| P/S市销率 | 14.47x | 3.19 | |
| Earnings yield盈利收益率 | 5.01% | 2.56 | |
| FCF yield自由现金流收益率 | -0.28% | 4.11 | |
| EV/EBITDA企业价值/EBITDA | 73.64x | 18.26 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$616.3M2025
20202025
5-yr growth5年复合增速 426.7%
Earnings per share每股收益
$2.772025
20202025
Free cash flow自由现金流
-$25.0M2025
20202025
Operating margin营业利润率
20.0%
Net margin净利率
72.6%
FCF margin自由现金流利润率
-4.0%
Balance-sheet quality财务体质 4/9
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 69%
Warning警示
Leverage杠杆
Net debt / EBITDA净债务/EBITDA1.35
Current ratio流动比率4.10
Capital allocation资本配置
Buybacks (TTM)回购（TTM）$0
Stock-based comp股权薪酬$64.7M
Share count change (1y)股数变化（1年）-0.3%
Debt coming due到期债务
SEC filingsSEC 文件Debt schedule not loaded yet.到期债务尚未加载。
This panel is still catching up to the SEC filings for this listing. Check back soon — nothing is being estimated in its place.本面板仍在同步该证券的 SEC 文件，请稍后再查看；此处不作任何估算替代。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。
Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前，已披露事实与现金流情景保持分离。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Quiet — no confirmed driver平静 — 无明确驱动
Technical技术面
TGTX took relative-strength leadershipTGTX 取得相对强弱领先
Signal history信号历史
engine events引擎事件
UNCONFIRMED TURN → NEARING A HIGH未确认转向 → 接近高点
TAKE PROFITS. A daily bottoming setup did fire (swing low in, momentum turned up), but it's LATE — price is already extended above the cycle low (formed ~8 day(s) ago @ 53.04) and momentum is fading — the 3-day/weekly momentum has crossed down. A momentum cross is a LAGGING confirmation: after a vertical run it only triggers once the move is mature, so the bottoming entry has already passed. This is a chase, not a fresh buy止盈。日线筑底形态确实已经触发（摆动低点出现、动量转向上行），但为时已晚——价格已显著高于周期低点（约 8 天前形成 @ 53.04）且动量正在衰竭——3 日/周线动量已向下交叉。动量交叉属于滞后确认：在垂直拉升之后，只有当走势已经成熟时才会触发，因此筑底入场早已错过。这是追高，而非新的买入
Sep 22, 2026
TGTX took relative-strength leadershipTGTX 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $58.11.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$58.11。
Sep 18, 2026
TGTX daily MACD crossed upTGTX 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $56.87.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$56.87。
Sep 17, 2026
NEARING A HIGH → UNCONFIRMED TURN接近高点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 16, 2026
UNCONFIRMED TURN → NEARING A HIGH未确认转向 → 接近高点
TAKE PROFITS止盈
Sep 16, 2026
TGTX StochRSI turned up from oversoldTGTX StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $55.85.StochRSI重回20上方 — 下行动量趋缓的最早预警。$55.85。
Sep 11, 2026
TGTX weekly MACD crossed downTGTX 周线MACD下穿
The weekly MACD histogram turned negative — the slower, less-whippy momentum read.周线MACD柱状图转负 — 更慢、更少来回的动量信号。
Sep 11, 2026
TGTX daily MACD crossed downTGTX 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $53.89.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$53.89。
Sep 8, 2026
BOTTOMING → UNCONFIRMED TURN筑底中 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 4, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Sep 4, 2026
TGTX weekly MACD crossed upTGTX 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Showing the last 15 of显示最近15条，共 245 signals条信号
Company profile公司档案
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Above market高于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
- Receivables stretch
- Capital intensity rising
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 19.9× | 29.6× | 76% |
| Price / Book市净率 | 13.8× | 3.3× | 8% |
| Price / Sales市销率 | 14.5× | 3.2× | 7% |
| EV / EBITDAEV/EBITDA | 73.6× | 18.3× | 6% |
| Earnings yield盈利收益率 | 5.0% | 2.6% | 83% |
| Free-cash-flow yield自由现金流收益率 | -0.3% | 5.5% | 8% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
90/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
71/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
94/100 — stronger than most强于多数
vs market, 12 months相对大盘（12个月）
87/100 — stronger than most强于多数
Rank in sector行业内排名
#23 / 173
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +1.0% | +1.3% |
| 1 Month近1月 | +4.4% | +0.9% |
| 3 Months近3月 | +2.9% | +6.1% |
| 6 Months近6月 | +80.9% | +22.3% |
| Year to date年初至今 | +96.1% | +13.8% |
| 1 Year近1年 | +65.8% | +18.5% |
| 3 Years近3年 | +554.8% | +87.8% |
Trading information交易信息
Beta vs market贝塔
0.54
Volatility rank波动率分位
17th pctile
Short interest空头占比
19.4% of float
Market cap市值
$9B
EPS (trailing)每股收益
$2.88
Off 52-week high距52周高点
-2.8%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $152,000 | $7M | $3M | $234M | $329M | $616M |
| EPS每股收益 | $-2.42 | $-2.63 | $-1.46 | $0.09 | $0.15 | $2.77 |
| Free cash flow自由现金流 | $-215M | $-296M | $-176M | $-31M | $-41M | $-25M |
| Gross margin毛利率 | — | — | — | 94.0% | 88.3% | 83.7% |
| Net margin净利率 | -183803.3% | -5204.1% | -7121.5% | 5.4% | 7.1% | 72.6% |
| FCF margin自由现金流利润率 | -141357.9% | -4425.7% | -6326.2% | -13.4% | -12.3% | -4.1% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$616M
Net income净利润
$447M
Operating cash flow经营现金流
$-25M
Total assets总资产
$1.1B
Shareholder equity股东权益
$648M
Long-term debt长期负债
$246M
Shares outstanding总股本
0.16B
Returns & growth回报与增长
Return on equity股本回报率
69.0%
Return on assets资产回报率
42.1%
Debt / assets负债/资产
23.1%
Profit growth利润增速
+1811.1%
Asset growth资产增速
+84.1%
Accounting quality checks会计质量检查
- Earnings quality: accruals trending up over 6 fiscal years — earnings increasingly not cash-backed盈利质量：应计利润在 6 个财年间走高——盈利的现金支撑减弱
- Working capital: inventory +215% vs sales +164%; receivables +21903% vs sales +9113% — demand & revenue-quality risk营运资本：存货 +215% 对销售 +164%；应收 +21903% 对销售 +9113%——需求与营收质量风险
- Pricing power: gross margin −10.3pts over 3 years定价能力：毛利率 3 年下降 10.3 个百分点
- Capital discipline: share count +10.5% over 6 years (dilution)资本纪律：股本 6 年增加 10.5%（稀释）
- Balance sheet: Altman Z 12.96 — safe zone资产负债表：Altman Z 12.96——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
58
RSI (2-day)RSI（2日）
60
vs 20-day average相对20日均线
+2.9%
vs 50-day average相对50日均线
+7.1%
vs 200-day average相对200日均线
+41.1%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up动能向上
3-day3日线
momentum down — turning up soon动能向下——接近转强
Weekly周线
momentum down — fresh downturn动能向下——刚刚转弱
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
CoiledCOILED
Days compressed已压缩天数
5
Range width percentile波幅宽度分位
10/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $0.05 | $0.41 | -87.8% |
| Mar 2026 | $0.17 | $0.23 | -26.1% |
| Dec 2025 | $0.14 | $0.35 | -60.0% |
| Sep 2025 | $2.43 | $0.24 | +912.5% |
Estimate revisions预期修正
Analysts covering覆盖分析师
4
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
+3.2%
Net upgrades, 30 days净上调（30天）
+0
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Insiders & shorts内部人与空头
Short interest空头占流通盘
19.4%
Days to cover回补天数
18.5
Short interest change空头变化
+0.1%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Jun · 100%
Weakest month最弱月份
Jan · 33%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -0.6% | 3 |
| Feb2月 | 67% | +2.8% | 3 |
| Mar3月 | 67% | +11.1% | 3 |
| Apr4月 | 67% | +2.3% | 3 |
| May5月 | 67% | +13.2% | 3 |
| Jun6月 | 100% | +9.6% | 3 |
| Jul7月 | 33% | -0.7% | 3 |
| Aug8月 | 50% | +5.7% | 4 |
| Sep9月 | 75% | +6.0% | 4 |
| Oct10月 | 33% | -3.5% | 3 |
| Nov11月 | 67% | +36.4% | 3 |
| Dec12月 | 33% | -10.4% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。